Skip to main content

Table 1 Demographic data of pediatric cases who had undergone liver and kidney transplantation (N = 51)

From: Pediatric liver and kidney transplantation in the era of COVID-19: a follow-up study from a tertiary referral center in Iran

Variable

Total (N or Mean ± SD)

Kidney Tx recipients (n = 11)

Liver Tx recipients (n = 40)

Age (years)

6.72 ± 5.47

7.72 ± 4.91

6.11 ± 5.80

Sex

 Male

33 (64.7)

4

29

 Female

18 (35.3)

7

11

White blood cells

8.79 ± 5.57

9.01 ± 6.77

8.66 ± 5.32

Creatinine (mg/dL)

0.64 ± 1.04

0.80 ± 1.00

0.61 ± 0.95

Aspartate transaminase (U/L)

161.58 ± 132.52

21.39 ± 19.88

171.21 ± 134.01

Alanine aminotransferase (U/L)

98.75 ± 80.93

14.33 ± 10.00

112.67 ± 99.07

Total Bilirubin (mg/dL)

17.96 ± 16.88

1.22 ± 1.00

19.08 ± 17.23

PELD score

21.20 ± 8.88

21.20 ± 8.88

Patients outcome

 Alive

40 (78.4)

11

29

 Expired

11 (21.6)

0

11

Immunosuppressive regimen

 Tacrolimus + prednisolone

32(62.74%)

1

31

 Mycophenolate mofetil + tacrolimus

9 (17.64%)

1

8

 Cyclosporine + prednisolone

10(19.60%)

9

1

Induction regimen

Methylprednisolone

41(80.39%)

8

33

Thymoglobulin

10 (19.6%)

3

7

Post-transplant laboratory value

O2 saturation (%)

91

93

90

 Lymphocytopenia

5 (10.6%)

2

3

 Lymphocytosis

13 (27.7%)

1

12

 Elevated CRP

19 (51.4%)

10

9

 Elevated ESR

8 (22.9%)

3

5

 Prograf level(ng/dl)

4.91 ± 2.21

5.82 ± 1.99

4.88 ± 2.01

 Cyclosporine level

190.34 ± 34.12

194.00 ± 36.21

188.30 ± 30.01

 CMV PCR positive

4 (14.8%)

3

1

  1. Tx, transplant; PELD, Pediatric end-stage liver disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; CMV, cytomegalovirus; PCR, polymerase chain reaction